Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its AllplexTM SARS-CoV-2/FluA/FluB/RSV Assay
Real-time test differentiates influenza A & B, RSV and COVID-19 SEOUL, South Korea--(BUSINESS WIRE)--Seegene Inc. (KQ096530), a biotechnology company specializing...







